Korea Investment CORP Sells 35,230 Shares of Stryker Co. (NYSE:SYK)

Korea Investment CORP lessened its holdings in Stryker Co. (NYSE:SYK - Free Report) by 10.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 301,230 shares of the medical technology company's stock after selling 35,230 shares during the quarter. Korea Investment CORP owned 0.08% of Stryker worth $108,458,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in the business. Kohmann Bosshard Financial Services LLC bought a new stake in Stryker during the fourth quarter worth $25,000. Dunhill Financial LLC raised its holdings in shares of Stryker by 94.9% in the 3rd quarter. Dunhill Financial LLC now owns 76 shares of the medical technology company's stock valued at $27,000 after purchasing an additional 37 shares during the period. Rakuten Securities Inc. lifted its stake in Stryker by 618.2% in the 4th quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company's stock valued at $28,000 after purchasing an additional 68 shares during the last quarter. Centricity Wealth Management LLC bought a new position in Stryker during the fourth quarter worth about $30,000. Finally, BankPlus Trust Department acquired a new position in Stryker during the fourth quarter worth approximately $33,000. Institutional investors and hedge funds own 77.09% of the company's stock.

Analyst Ratings Changes

Several research analysts have recently commented on SYK shares. Truist Financial lifted their target price on Stryker from $409.00 to $413.00 and gave the stock a "hold" rating in a research note on Thursday, January 30th. Citigroup reiterated a "buy" rating and issued a $450.00 price objective on shares of Stryker in a report on Wednesday, February 26th. Argus set a $450.00 target price on shares of Stryker in a research note on Monday, February 3rd. Stifel Nicolaus upped their price target on shares of Stryker from $400.00 to $440.00 and gave the company a "buy" rating in a research note on Wednesday, January 29th. Finally, The Goldman Sachs Group set a $422.00 price objective on shares of Stryker in a research report on Tuesday, March 4th. Five analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat, Stryker has a consensus rating of "Moderate Buy" and a consensus price target of $421.90.

Remove Ads

Insider Buying and Selling at Stryker

In related news, Director Ronda E. Stryker sold 201,392 shares of the business's stock in a transaction on Friday, January 31st. The stock was sold at an average price of $392.24, for a total transaction of $78,993,998.08. Following the sale, the director now owns 3,642,075 shares in the company, valued at $1,428,567,498. The trade was a 5.24 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Allan C. Golston sold 2,458 shares of the stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $383.07, for a total value of $941,586.06. Following the completion of the transaction, the director now owns 14,895 shares of the company's stock, valued at $5,705,827.65. This represents a 14.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 5.90% of the company's stock.

Stryker Price Performance

SYK traded down $3.16 during trading on Friday, hitting $364.38. 1,274,307 shares of the stock traded hands, compared to its average volume of 1,289,456. The business has a 50 day moving average price of $384.08 and a 200 day moving average price of $374.32. The company has a market cap of $139.08 billion, a price-to-earnings ratio of 46.96, a PEG ratio of 2.93 and a beta of 0.95. Stryker Co. has a twelve month low of $314.93 and a twelve month high of $406.19. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.95 and a quick ratio of 1.32.

Stryker (NYSE:SYK - Get Free Report) last posted its quarterly earnings results on Tuesday, January 28th. The medical technology company reported $4.01 EPS for the quarter, topping analysts' consensus estimates of $3.87 by $0.14. Stryker had a return on equity of 23.58% and a net margin of 13.25%. During the same quarter in the previous year, the company posted $3.46 earnings per share. Equities research analysts forecast that Stryker Co. will post 13.47 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 30th. Investors of record on Monday, March 31st will be given a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a yield of 0.92%. The ex-dividend date of this dividend is Monday, March 31st. Stryker's dividend payout ratio is 43.30%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.